CANCER CELL BIOLOGY AND SIGNALING PROGRAMThe Cancer Cell Biology and Signaling Program is comprised of nineteen investigators from sixdepartments. The program mission is to elucidate the role of cell signaling in regulating cell growth,differentiation, and apoptosis. The program focuses on three major areas of research: 1) understanding themolecular mechanisms involved in the regulation of cell growth and differentiation with an emphasis on therole of tyrosine kinase and G protein-coupled receptor signaling pathways; 2) elucidating the molecularmechanisms regulating cell apoptosis; and 3) addressing the role of the extracellular matrix in regulatingcell growth and migration.An important scientific goal of this program is to integrate fundamental studies on the mechanisms thatregulate cell growth, differentiation, and apoptosis with the translational research efforts at the KCC. Thisshould result in a better understanding of the biology of cancer and also in the translation of basic researchinto novel therapeutic strategies for the treatment of cancer. All program members are NIH funded. Theycurrently have $2.6 million of NCI support and $9.8 million of total, peer-reviewed support. Programmembers published a total of 320 cancer-relevant manuscripts (8% intra-programmatic and 13% interprogrammatic)during the last grant period.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA056036-09
Application #
7712901
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-09-05
Project End
2013-05-31
Budget Start
2008-09-05
Budget End
2009-05-31
Support Year
9
Fiscal Year
2008
Total Cost
$25,577
Indirect Cost
Name
Thomas Jefferson University
Department
Type
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Peng, Weidan; Furuuchi, Narumi; Aslanukova, Ludmila et al. (2018) Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor Development. Mol Cell Biol 38:
Waldman, Scott A; Camilleri, Michael (2018) Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders. Gut 67:1543-1552
Sullivan-Reed, Katherine; Bolton-Gillespie, Elisabeth; Dasgupta, Yashodhara et al. (2018) Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells. Cell Rep 23:3127-3136
Lu, Huimin; Bowler, Nicholas; Harshyne, Larry A et al. (2018) Exosomal ?v?6 integrin is required for monocyte M2 polarization in prostate cancer. Matrix Biol 70:20-35
Lapadula, Dominic; Farias, Eduardo; Randolph, Clinita E et al. (2018) Effects of Oncogenic G?q and G?11 Inhibition by FR900359 in Uveal Melanoma. Mol Cancer Res :
Vite, Alexia; Zhang, Caimei; Yi, Roslyn et al. (2018) ?-Catenin-dependent cytoskeletal tension controls Yap activity in the heart. Development 145:
McNair, Christopher; Xu, Kexin; Mandigo, Amy C et al. (2018) Differential impact of RB status on E2F1 reprogramming in human cancer. J Clin Invest 128:341-358
Garcia, Samantha A; Lebrun, Aurore; Kean, Rhonda B et al. (2018) Clearance of attenuated rabies virus from brain tissues is required for long-term protection against CNS challenge with a pathogenic variant. J Neurovirol 24:606-615
Vido, Michael J; Le, Kaitlyn; Hartsough, Edward J et al. (2018) BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK Association. Cell Rep 25:1501-1510.e3
Brody, Jonathan R; Dixon, Dan A (2018) Complex HuR function in pancreatic cancer cells. Wiley Interdiscip Rev RNA 9:e1469

Showing the most recent 10 out of 807 publications